Search the Newsreel

Merit Medical Systems (NASDAQ: MMSI) Q2 earnings rise on margin gains

Merit Medical Systems reported a strong Q2 2026, with net sales increasing by 9.5% to $418.8 million and net income rising to $38.8 million, or $0.65 diluted EPS, driven by improved gross profit margins. The company's foundational and therapeutic product categories both saw significant …

Merit Medical reports $418.8M revenue and 9% organic growth

Merit Medical (NASDAQ: MMSI) reported strong second-quarter 2026 financial results, with revenue up 10% to $418.8 million and organic growth of 9%. The company also raised its full-year 2026 revenue guidance to $1.631–$1.643 billion and non-GAAP EPS guidance to $4.25–$4.35, reflecting confidence in continued …

Merit Medical Systems (NASDAQ:MMSI) Updates FY 2026 Earnings Guidance

Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Earnings To Watch: Merit Medical Systems (MMSI) Reports Q2 Results Tomorrow

Merit Medical Systems (MMSI) is set to announce its Q2 earnings results after the bell tomorrow. The market anticipates a 6% year-on-year revenue growth. The company has a history of exceeding Wall Street's expectations and has seen positive investor sentiment in the healthcare equipment …

Merit Medical Systems Inc (MMSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Merit Medical Systems Inc (MMSI), focusing on its stock price momentum, support and resistance levels, and various technical indicators and moving averages. While the overall signal from technical indicators is Neutral, moving averages show strong buy signals. …

Merit Medical Systems Inc (MMSI) Cash Flow

This article provides a detailed historical cash flow statement for Merit Medical Systems Inc (MMSI), covering operating, investing, and financing activities on a quarterly and annual basis. It includes key financial metrics like operating cash flow, capital expenditures, financing cash flow, and free cash …

Merit Medical Systems Inc (MMSI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Merit Medical Systems Inc (MMSI), listing its major shareholders and their respective proportions, including BlackRock Institutional Trust Company and Vanguard. It also categorizes shareholders by type, such as Investment Advisors and Hedge Funds, and provides a history …

MMSI|Merit Medical Systems Inc|Price:74.320|Chg%:+1.210

This article provides a detailed financial overview of Merit Medical Systems Inc (MMSI), including its stock performance, market capitalization, P/E ratio, and upcoming earnings date. It presents comprehensive quarterly and annual financial data, such as EPS, revenue, net profit, net margin, gross margin, and …

Merit Medical Systems, Inc. Revenue Breakdown – FWB:MM3

Merit Medical Systems, Inc. (FWB:MM3) generated 1.29 billion EUR in revenue last year, with its Cardiovascular segment contributing the most at 1.23 billion EUR. The United States was the company's largest regional contributor, accounting for 774.34 million EUR. This financial data highlights the company's …

Merit Medical Systems Inc (MMSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Merit Medical Systems Inc (MMSI), segmenting its revenue by business and region. As of April 6, the company's revenue streams are primarily from Peripheral Intervention, Cardiac Intervention, Custom Procedural Solutions, OEM, and Endoscopy devices. Regionally, the …

Merit Medical Systems, Inc. Revenue Breakdown – LSX:882361

Merit Medical Systems, Inc. generated 1.29 billion EUR in revenue last year, with its Cardiovascular segment contributing the most at 1.23 billion EUR. The United States was the largest regional contributor, accounting for 774.34 million EUR. These figures indicate the company's primary revenue streams …

US589889AA2 Bond Profile — Key Metrics

This article provides key metrics for the Merit Medical Systems, Inc. 3.0% 01-FEB-2029 bond, identified by US589889AA2, traded on the Frankfurt Stock Exchange. It details the issuer's business, bond specifics like coupon rate and maturity, and provides company background information.

US589889AA2 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the US589889AA2 bond issued by Merit Medical Systems, Inc. It highlights that the bond has a current coupon rate of 3.00% and its next payment is scheduled for August 3, 2026. The page offers an overview of …

US589889AA2 Bond Risk Profile

This page provides a risk profile for the Merit Medical Systems, Inc. 3.0% 01-FEB-2029 bond, identified as US589889AA2 on the Frankfurt Stock Exchange. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help users evaluate the …

Merit Medical Systems (MMSI) Projected to Post Earnings on Thursday

Zacks Research Has Pessimistic Outlook of MMSI Q3 Earnings

Price-Driven Insight from (MMSI) for Rule-Based Strategy

This article provides a price-driven analysis of Merit Medical Systems Inc. (MMSI) for rule-based trading strategies. It highlights a strong near to mid-term sentiment but a weak long-term outlook, with no resistance levels identified above the current price. The report details specific institutional trading …

Merit Medical Systems (MMSI) Stock May Be 29% Undervalued On Product Expansion News

Merit Medical Systems (MMSI) stock shows a mixed valuation, with a Discounted Cash Flow (DCF) model suggesting it is 29.3% undervalued at an intrinsic value of $104.62 per share, primarily due to recent product launches and acquisitions in oncology and endoscopy. However, its P/E …

Merit Medical stock trades steady as investors weigh growth and margins

Merit Medical Systems Inc. (NASDAQ: MMSI) stock is being evaluated by investors based on its double-digit revenue growth and improving margins. The company, a US-based medical device manufacturer, focuses on minimally invasive therapies and operates in a competitive global market. Key factors include sustained …